Retrospective analysis of definitive radiotherapy for patients with superficial esophageal carcinoma: Consideration of the optimal treatment method with a focus on late morbidity

Radiotherapy and Oncology

Volumn 95, Issue 2, 2010, Pages 234-239

  Kodaira, Takeshi ^a   Fuwa, Nobukazu ^a   Tachibana, Hiroyuki ^a   Nakamura, Tatsuya ^a   Tomita, Natsuo ^a   Nakahara, Rie ^a   Inokuchi, Haruo ^a   Mizoguchi, Nobutaka ^a   Takada, Akinori ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Definitive radiotherapy Iodine staining; Second primary; Superficial esophageal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS DISEASE; ESOPHAGUS STENOSIS; ESOPHAGUS ULCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; CANCER INVASION; CANCER STAGING; ESOPHAGUS TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77956627681     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.01.005     Document Type: Article

References (18)

1. Center for Cancer Control and Information Services, National Cancer Center, Japan.
2. Registration Committee for Esophageal Cancer (ed.), Comprehensive registry of esophageal cancer in Japan, The Japan Society for Esophageal Diseases.
3. Nishimura Y, Okuno Y, Ono K, Mitsumori M, Nagata Y, Hiraoka M. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma. Cancer 1999;86: 220-8. (Pubitemid 29327578)
4. Okawa T, Dokiya T, Nishio M, Hishikawa Y, Morita K. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Int J Radiat Oncol Biol Phys 1999;45: 623-8. (Pubitemid 29462641)
5. Yamada K, Murakami M, Okamoto Y, et al. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma. Int J Radiat Oncol Biol Phys 2006;64: 1106-11.
6. Nemoto K, Matsumoto Y, Yamakawa M, et al. Treatment of superficial esophageal cancer by external radiation therapy alone: results of a multiinstitutional experience. Int J Radiat Oncol Biol Phys 2000;46: 921-5. (Pubitemid 30114405)
7. Nemoto K, Yamada S, Hareyama M, Nagakura H, Hirokawa Y. Radiation therapy for superficial esophageal cancer: a comparison of radiotherapy methods. Int J Radiat Oncol Biol Phys 2001;50: 639-44. (Pubitemid 32515320)
8. Kodaira T, Fuwa N, Kamata M, Furutani K, Tachibana H, Yamazaki T. Singleinstitute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma. Anticancer Res 2006;26: 471-8. (Pubitemid 43206004)
9. Kodaira T, Fuwa N, Itoh Y, et al. Multivariate analysis of treatment outcome in patients with esophageal carcinoma treated with definitive radiotherapy. Am J Clin Oncol 2003;26: 392-7. (Pubitemid 36962085)
10. Yorozu A, Dokiya T, Oki Y. High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 1999;45: 271-5. (Pubitemid 29408538)
11. Fuwa N, Nomoto Y, Shouji K, Kodaira T, Kamata M, Ito Y. Therapeutic effects of simultaneous intraluminal irradiation and intraluminal hyperthermia on oesophageal carcinoma. Br J Radiol 2001;74: 709-14. (Pubitemid 32791544)
12. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53: 457-81.
13. Mantle N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50: 163-70.
14. Cox D. Regression models and life table. J R Stat Soc 1972;34: 197-220.
15. Shinoda M, Hatooka S, Mori S, Mitsudomi T. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer. Ann Thorac Cardiovasc Surg 2006;12: 234-41.
16. Akagi Y, Hirokawa Y, Kagemoto M, et al. Optimum fractionation for high-doserate endoesophageal brachytherapy following external irradiation of early stage esophageal cancer. Int J Radiat Oncol Biol Phys 1999;43: 525-30. (Pubitemid 29107170)
17. Gaspar LE, Winter K, Kocha WI, Coia LR, Herskovic A, Graham M. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report. Cancer 2000;88: 988-95. (Pubitemid 30127657)
18. Ishikura S, Nihei K, Ohtsu A, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21: 2697-702. (Pubitemid 46606313)